tiprankstipranks
Trending News
More News >
Evaxion Biotech A/S Adr (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Financial Statements

Compare
387 Followers

Evaxion Biotech Financial Overview

Evaxion Biotech's market cap is currently $30.26M. The company's EPS TTM is $0.01; its P/E ratio is ―; Evaxion Biotech is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 3.34M$ 73.00K$ 0.00$ 0.00$ 0.00
Gross Profit$ 3.34M$ 73.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -14.73M$ -22.20M$ -25.26M$ -25.83M$ -16.57M
EBITDA$ -9.79M$ -21.40M$ -22.57M$ -24.21M$ -16.46M
Net Income$ -10.57M$ -22.13M$ -23.17M$ -24.53M$ -15.02M
Balance Sheet
Cash & Short-Term Investments$ 5.05M$ 4.18M$ 13.18M$ 32.17M$ 5.83M
Total Assets$ 12.48M$ 12.89M$ 22.02M$ 40.16M$ 11.96M
Total Debt$ 10.10M$ 10.87M$ 10.26M$ 3.69M$ 20.00K
Net Debt$ 5.05M$ 6.69M$ -2.93M$ -28.48M$ -5.81M
Total Liabilities$ 14.14M$ 17.62M$ 13.72M$ 7.73M$ 4.93M
Stockholders' Equity$ -1.65M$ -4.73M$ 8.30M$ 32.44M$ 7.04M
Cash Flow
Free Cash Flow$ -12.94M$ -17.78M$ -26.07M$ -23.29M$ -12.83M
Operating Cash Flow$ -12.94M$ -17.69M$ -25.77M$ -21.93M$ -12.44M
Investing Cash Flow$ -3.00K$ -93.00K$ -268.00K$ -1.33M$ -393.00K
Financing Cash Flow$ 13.13M$ 10.69M$ 7.85M$ 49.80M$ 8.82M
Currency in USD

Evaxion Biotech Earnings and Revenue History

Evaxion Biotech Debt to Assets

Evaxion Biotech Cash Flow

Evaxion Biotech Forecast EPS vs Actual EPS